These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24140727)

  • 1. Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.
    Liu XC; Holtze M; Powell SB; Terrando N; Larsson MK; Persson A; Olsson SK; Orhan F; Kegel M; Asp L; Goiny M; Schwieler L; Engberg G; Karlsson H; Erhardt S
    Brain Behav Immun; 2014 Feb; 36():80-9. PubMed ID: 24140727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.
    Asp L; Holtze M; Powell SB; Karlsson H; Erhardt S
    Int J Neuropsychopharmacol; 2010 May; 13(4):475-85. PubMed ID: 19607757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of the kynurenine pathway by neurotropic influenza A virus infection.
    Holtze M; Asp L; Schwieler L; Engberg G; Karlsson H
    J Neurosci Res; 2008 Dec; 86(16):3674-83. PubMed ID: 18655201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
    Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
    Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia.
    Iaccarino HF; Suckow RF; Xie S; Bucci DJ
    Schizophr Res; 2013 Nov; 150(2-3):392-7. PubMed ID: 24091034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice.
    Olsson SK; Larsson MK; Erhardt S
    J Neural Transm (Vienna); 2012 Feb; 119(2):155-63. PubMed ID: 21904895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.
    Pershing ML; Phenis D; Valentini V; Pocivavsek A; Lindquist DH; Schwarcz R; Bruno JP
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3725-3735. PubMed ID: 27527585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
    Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
    Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous kynurenic acid disrupts prepulse inhibition.
    Erhardt S; Schwieler L; Emanuelsson C; Geyer M
    Biol Psychiatry; 2004 Aug; 56(4):255-60. PubMed ID: 15312813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.
    Erhardt S; Pocivavsek A; Repici M; Liu XC; Imbeault S; Maddison DC; Thomas MAR; Smalley JL; Larsson MK; Muchowski PJ; Giorgini F; Schwarcz R
    Biol Psychiatry; 2017 Nov; 82(10):756-765. PubMed ID: 28187857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.
    Akagbosu CO; Evans GC; Gulick D; Suckow RF; Bucci DJ
    Schizophr Bull; 2012 Jun; 38(4):769-78. PubMed ID: 21172906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.
    Alexander KS; Pocivavsek A; Wu HQ; Pershing ML; Schwarcz R; Bruno JP
    Neuroscience; 2013 May; 238():19-28. PubMed ID: 23395862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus.
    Alkondon M; Pereira EF; Yu P; Arruda EZ; Almeida LE; Guidetti P; Fawcett WP; Sapko MT; Randall WR; Schwarcz R; Tagle DA; Albuquerque EX
    J Neurosci; 2004 May; 24(19):4635-48. PubMed ID: 15140935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic transamination of D-kynurenine generates kynurenic acid in rat and human brain.
    Pérez-de la Cruz V; Amori L; Sathyasaikumar KV; Wang XD; Notarangelo FM; Wu HQ; Schwarcz R
    J Neurochem; 2012 Mar; 120(6):1026-35. PubMed ID: 22224417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood.
    Pocivavsek A; Wu HQ; Elmer GI; Bruno JP; Schwarcz R
    Eur J Neurosci; 2012 May; 35(10):1605-12. PubMed ID: 22515201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats.
    Pocivavsek A; Thomas MA; Elmer GI; Bruno JP; Schwarcz R
    Psychopharmacology (Berl); 2014 Jul; 231(14):2799-809. PubMed ID: 24590052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
    Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
    J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid.
    Fukuwatari T
    Nutrients; 2020 May; 12(5):. PubMed ID: 32414200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.